- For US Healthcare Providers
- Full Prescribing Information
SIMPONI ARIA® IS THE ONLY FULLY HUMAN IV ANTI-TNFα APPROVED TO TREAT:

FIRST-LINE BIOLOGIC
COMMERCIAL COVERAGE1*
Under the medical benefit with no subcutaneous step therapy
Coverage rate is for rheumatoid arthritis and psoriatic arthritis only.
*These percentages may not represent 100% of formulary lives due to data limitations.
Source: 1. Managed Markets Insight & Technology, LLC™, a trademark of MMIT, as of June 2022.